Compare ICU & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICU | ENLV |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 4.0M |
| IPO Year | 2021 | 2014 |
| Metric | ICU | ENLV |
|---|---|---|
| Price | $0.90 | $1.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 238.6K | 95.1K |
| Earning Date | 11-11-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,234,000.00 | N/A |
| Revenue This Year | $72.04 | N/A |
| Revenue Next Year | $38.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 814.07 | N/A |
| 52 Week Low | $0.22 | $0.16 |
| 52 Week High | $5.38 | $7.64 |
| Indicator | ICU | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 26.56 | 49.47 |
| Support Level | N/A | $1.02 |
| Resistance Level | $3.53 | $1.26 |
| Average True Range (ATR) | 0.20 | 0.12 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 8.73 | 20.54 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.